Imatinib Recruiting Phase 1 Trials for Chronic Myelogenous Leukemia (CML) / Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia Health Services Research

IndicationsStatusPurposePhase
RecruitingHealth Services Research1
clinicaltrials.gov IdentifierTitleDrugs
NCT02081378A Phase I Study of Oral ABL001 in Patients With CML or Ph+ ALL